key: cord-0799356-m9t6cevx authors: Tada, Masako; Tada, Takashi title: Epigenetic Reprogramming of Somatic Genomes by Electrofusion With Embryonic Stem Cells date: 2006 journal: Nuclear Reprogramming DOI: 10.1385/1-59745-005-7:67 sha: 9b580c4851c342dd8a93a91bf0b724a16f8affed doc_id: 799356 cord_uid: m9t6cevx Cell fusion is an approach for combining genetic and epigenetic information between two different types of cells. Electrofusion for generating hybrid cells between mouse embryonic stem cells and somatic cells, which is a type of nonchemically induced and nonvirus-mediated cell fusion, is introduced here as a highly effective, reproducible, and biomedically safe in vitro system. Under optimized electrofusion conditions, cells are aligned and form pearl chains between electrodes in response to AC pulse stimulation, and subsequently adjacent cytoplasmic membranes are fused by DC pulse stimulation. Hybrid cells survive as drug-resistant colonies in selection medium. Cell fusion is a technique that is applied widely in the life sciences. A recent topic of great interest in the field of stem cell research is the successful production of cloned animals via epigenetic reprogramming of somatic nuclei. Interestingly, nuclear reprogramming for conferring pluripotency on somatic nuclei also occurs via cell fusion between pluripotential stem cells and somatic cells. Furthermore, it has been shown that spontaneous cell fusion contributes to generating the intrinsic plasticity of tissue stem cells. Cell fusion technology may make important contributions to the fields of regenerative medicine and epigenetic reprogramming. Fertilization is one of the well-known cell fusion phenomena occurring in vivo. The union of two pronuclei from an MII oocyte and a sperm creates the next generation and endows it with genetic and epigenetic diversity. Genetically programmed spontaneous cell fusion also is known to occur in the formation of polykaryones, such as myotubes, osteoclasts, and syntrophoblasts in vivo. Remarkably, recent developments in the field of stem cell research have revealed that spontaneous cell fusion plays an important role in maintaining homeostasis of many tissues and organs via degeneration during defined processes of self-renewal and after tissue damage. The capability of spontaneous cell fusion has been shown by the generation of hybrid cells via in vitro coculturing of mouse bone marrow cells and embryonic stem (ES) cells (1) and of mouse brain cells and ES cells (2,3) . The in vivo contribution of spontaneous cell fusion to regeneration of tissues has been proven by the transdifferentiation of bone-marrow-derived hybrid cells into Purkinje neurons, cardiomyocytes, and hepatocytes (4-7). A fascinating breakthrough in the area of stem cell research is the successful production of cloned animals via transplantation of committed somatic cell nuclei into enucleated unfertilized oocytes (8). This technique recently has been applied to generate human ES cells derived from cloned blastocysts (9). Nuclear reprogramming from the "somatic type" to the "pluripotential type" is induced by genome-wide epigenetic changes via the activity of trans-acting factors in unfertilized oocytes. Interestingly, using electrofusion between ES cells and adult somatic cells, Tada et al. (10) demonstrated that ES cells have an intrinsic capacity for epigenetic reprogramming of somatic genomes. In hybrid cells between ES cells and thymocytes, nuclear reprogramming of somatic genomes has been shown by (1) the successful contribution of the ES hybrid cells to the normal embryogenesis of chimeric embryos, (2) reactivation of the inactivated X chromosome derived from female thymocytes, (3) reactivation of pluripotential cell-specific genes (Oct4 and Tsix ) derived from somatic cells, (4) redifferentiation of a variety of cell types independent of the origin of thymocytes in teratomas, (5) tissue-specific gene expression from the reprogrammed somatic genomes after in vivo and in vitro differentiation, and (6) decondensed chromatin formation in the reprogrammed somatic nuclei as marked by histone-tail modifications of H3 and H4 hyperacetylation and H3 lysine 4 hypermethylation (10-13). Moreover, embryonic germ (EG) cells derived from gonadal primordial germ cells of mouse E11.5 and 12.5 embryos, in which most parental imprints are erased (14), possess additional potential for inducing the reprogramming of somatic cell-derived parental imprints accompanied by the demethylation of allele-specific DNA methylation in the EG hybrid cells (15) . Therefore, electrofusion between pluripotential stem cells and somatic cells will contribute to elucidating the mechanisms of epigenetic reprogramming involved in DNA and chromatin modifications. The technique of cell fusion pioneered in 1965 by Harris (16) has proven to be a powerful approach for analyzing biological interactions between differentiated cell types and for studying genomic plasticity (17) (18) (19) . It has been shown that cell fusion caused by membrane fusion between two different cells is induced by treatment with various chemical agents, such as calcium ions, lyso-lecithin, and polyethylene glycol and also by mediation with viruses such as paramyxoviruses, including Sendai virus (i.e., HVJ), oncornavirus, coronavirus, herpesvirus, and poxvirus. However, chemical and virus-mediated cell fusion has difficulties with respect to the efficiency of inducing cell fusion and also with respect to the reproducibility and biomedical safety when used for clinical applications. Since the 1980s, efforts have been made to optimize many parameters of electrofusion, resulting in the improvement of the fusion efficiency, which is higher than that of cell fusion with polyethylene glycol (20). However, the electrofusion parameters were optimized for making hybridomas for the purpose of stable production of antibodies. In this chapter, we introduce an experimental procedure to create hybrid cells by electrofusion between pluripotential stem cells and somatic cells. For this procedure, a 2.5-mL syringe, 18-gage needle, and 50-mL conical tube are required. Adult mice, ES cells, and neo r primary embryonic fibroblasts (PEFs) produced from E12.5 embryos of ROSA26 transgenic mice carrying the ubiquitously expressed neo/lacZ gene (21). Set the optimized electrical parameters to fuse ES cells and thymocytes ( Fig. 2A,G) . 1. Coat 60-mm culture dishes with 0.1% gelatin for at least 30 min at 37ЊC. 2. Incubate neo r PEFs with 10 μg/mL MMC for 2 h at 37ЊC in a CO 2 incubator to produce mitotically inactivated feeder cells. Frozen stocks of MMC-treated PEFs are prepared at a cell concentration of 5 × 10 6 cells/mL/cryotube and are stored in liquid nitrogen. Inactivated neo r PEFs are routinely used as feeder cells (1 × 10 6 cells/60-mm culture dish and 2.5 × 10 6 cells/100-mm culture dish) for culture of ES and hybrid cells, and also for selection of hybrid cell colonies with G418. 1. One day before cell fusion, coat 30-mm culture wells (6-well culture plate) with 0.1% gelatin for at least 30 min at 37ЊC. 2. Prepare inactivated PEFs (4 × 10 5 cells/ 30-mm well) in 3 mL of ES medium (Fig. 2F ). One of the most important requirements for cell fusion experiments is that the culture conditions have to be optimized for maintaining the pluripotential competence and full set of chromosomes (80 chromosomes) derived from mouse ES cells and somatic cells through numerous cell divisions. It is strongly recommended that one identify a satisfactory production lot of FBS that can supply supplements to support effective cell growth without differentiation induction. changes of culture medium once or twice a day. 2. Ascertain that complete sets of chromosomes are maintained in the ES cells before cell fusion. 1. Sterilize all dissection instruments (scissors and forceps) by immersion in 70% ethanol, followed by flaming. 2. Sacrifice a 6-to 8-wk-old adult mouse humanely and dissect out the thymus in a clean room if a clean bench is not available. 3. Wash the tissues with sterilized PBS twice in 60-mm Petri dishes. 4. Place a half lobe of a thymus in the barrel of a sterile 2.5-mL syringe fitted with a sterile 18-gage needle (Fig. 2E) . 5. Expel and draw up the thymus gently through the needle via the tip of the needle several times into a 50-mL conical tube with 2 mL of DMEM to dissociate the thymus into a single-cell suspension. 6. Place for several minutes at room temperature. 7. Transfer the supernatant excluding cell clumps to a 15-mL conical tube and add 10 mL of DMEM. 8. Spin down the thymocytes in 15-mL conical tubes at > 400g (1500 rpm) for 5 min. 9. Resuspend them in 10 mL of DMEM. The automatic operation switch is used to initiate AC followed by DC. AC is used to induce a nonhomogeneous (or divergent) electric field, resulting in cell alignment and pearl chain formation. DC is used to produce reversible temporary pores in the cytoplasmic membranes. When juxtaposed pores in the physically associated cells reseal, cells have a chance to be hybridized by cytoplasmic membrane fusion. AC application after the DC pulse induces compression of the cells, which helps the process of fusion between the cell membranes. 3 . Place the chamber on an inverted microscope to allow for observation of cell alignment (Fig. 2D) . 4 . Press the automatic operation switch of the ECM 2001. 5. Add 40 μL of DMEM to the fusion mixture between the electrodes to induce membrane reformation immediately after electroporation. 6. Leave the cell mixture for 10 min at room temperature. 7. Transfer the cell mixture directly to a 30-mm culture dish containing inactivated PEFs with 3 mL of ES medium supplemented with LIF (Fig. 2F) . 8. Repeat the cell fusion procedure sequentially by using several Microslides. Usually, cell suspensions recovered from three Microslides (80 μL ×3) are plated into one 30-mm culture dish. As a control, plate the untreated cell mixture and culture under the same conditions. 9. Incubate the cells at 37°C in a CO 2 incubator for 24 h. 10. Change the medium to ES medium with the proper supplement to select for ES hybrid cells 24 h after cell fusion. 11. Change the selection medium once a day. As a result of the 7-d drug treatment, nonfused ES cells and hybrid cells derived from ES cells are killed, and hybrid cells derived from thymocytes are nonadherent. Thus, the hybrid cells derived from an ES cell and a somatic cell survive and form colonies. Several colonies of hybrid cells per 10 4 host ES cells appear using the aforementioned procedures for electrofusion. See Subheading 4. We describe two independent chemical selection systems to select for hybrid cells between ES cells and somatic cells. Normal ES cells are hybridized with thymocytes containing the bacterial neomycin resistance (neo r ) gene (10,15). Thymocytes are derived from ROSA26 transgenic mice, which carry the ubiquitously expressed neo/lacZ transgene (21). Only ES-thymocyte hybrid cells can survive and grow in ES medium supplemented with the protein synthesis inhibitor G418. In this case, the ES hybrid cells and their derivatives are visualized by positive reaction with X-gal through β-galactosidase activity, which allows us to analyze their contribution to the development of chimeric embryos and tissues (10,11,15 ). In another selection system, male ES cells deficient for the Hprt gene on the X chromosome have been used for selecting hybrids with wild-type somatic cells. Electrofusion-treated cells are cultured in ES medium supplemented with HAT. The HAT medium is fatal to the Hprtdeficient ES cells, whereas ES hybrid cells, which are rescued by the thymocyte-derived wild-type Hprt gene, are able to survive and grow (11-13) . In the synthesis of DNA, purine nucleotides can be synthesized by the de novo pathway and recycled by the salvage pathway. Hprt is a purine salvage enzyme responsible for converting the purine degradation product, hypoxanthine, to inosine monophosphate, a precursor of ATP and GTP. In the presence of aminopterin, the de novo pathway is inhibited and only the salvage pathway functions. Consequently, dysfunction of Hprt induces cell death in culture with the HAT medium. 1. Perform the automatic procedure for electrofusion of the mixture of normal ES cells and thymocytes collected from 6-to 8-wk-old ROSA26 transgenic mice carrying the neo/lacZ transgene. 2. Culture the electrofusion-treated cells in ES medium for 24 h. 3. Change the medium to ES medium supplemented with G418. ES hybrid cell colonies can be detected by 7 to 10 d. 4. Prepare a 24-well culture plate containing 1 × 10 5 inactivated neo r PEFs per 10mm well and 0.8 mL of ES medium supplemented with G418 for selection. 5. Pick up the colonies with a micropipette and transfer each colony into a 10-mm well of the 24-well culture plate on inactivated PEFs. 6. Subculture the colonies every 2 or 3 d and gradually expand the number of cells in 30-mm and 60-mm culture dishes with inactivated PEFs and ES medium. When the cells become nearly confluent in a 60-mm culture dish, we determine that a hybrid cell line is established at passage 1. 7. Analyze the karyotypes of the hybrid cells before using for further studies. • The total cell volumes in 0.3 M mannitol have to be carefully controlled to obtain a smooth electric current. When other somatic cells larger than thymocytes and similar-sized with ES cells are used as a fusion partner, prepare a 1/1 cell mixture at 2 × 10 6 cells/mL. Microslide chambers with 1-mm electrode gap (BTX P/N450-1) Micrograbber cables (BTX 464) Dulbecco's modified Eagle's medium/nutrient mixture F12 HAM (DMEM/F12; cat Dulbecco's modified Eagle's medium (DMEM; cat Fetal bovine serum (FBS; cat. no. 12003-78P Recombinant leukemia inhibitory factor (LIF; cat. no. ESG1107, Chemicon) 200 mM Glutamine (cat. no. 320-5030A G, Gibco) 000 U/mL Penicillin and 10 mg/mL streptomycin (penicillin-streptomycin 100X; cat 100 mM Sodium pyruvate (cat 5% Sodium bicarbonate Mg 2+ -free phosphate-buffered saline 25% Trypsin/1 mM ethylene diaminetetraacetic acid · 4Na (cat. no. 25200-056, Gibco) Gelatin from porcine skin, Type A (cat G418 (Geneticin; cat Hypoxanthine-aminopterin-thymine media supplement, 50X (HAT; cat. no. H0262, Sigma) PEFs medium: mix 500 mL of DMEM, 50 mL of FBS, 5 mL of 200 mM glutamine, 5 mL of 10,000 U/mL penicillin, and 10 mg/mL streptomycin ES medium: mix 500 mL of DMEM/F12, 75 mL of FBS, 5 mL of 200 mM glutamine, 5 mL of 100X penicillin-streptomycin, 5 mL of 100 mM sodium pyruvate, 8 mL of 7.5% sodium bicarbonate, 4 μL of 10 -4 M 2-mercaptoethanol, and 50 μL of 10 7 U/mL LIF 25% Trypsin/1 mM ethylenediaminetetraacetic acid · 4Na. Dispense into aliquots and store at -20ºC MMC) Prepare solution at 0.2 mg/mL in PBS, dispense into aliquots and store at -20ºC 1% Gelatin: dissolve 0.1 g of gelatin in 100 mL of distilled water. Sterilize by autoclaving and store at 4ºC Fresh nonelectrolyte solution: 0.3 M mannitol. Dissolve 2.74 g of mannitol in 50 mL of distilled water. Filter through a 0.2-μm filter ES medium with G418: dissolve antibiotic G418 in distilled water at 50 mg/mL. Sterilize through a 0.2-μm filter and store at 4ºC. Add 50 μL of the G418 solution to 10 mL of ES medium to obtain a final concentration of 250 μg/mL Use ES cells (XY) deficient for Hprt and normal thymocytes collected from 6-to 8-wk-old female (XX) or male (XY) mice Culture the electrofusion-treated cells in ES medium for 24 h Change the medium to ES medium supplemented with HAT. ES hybrid cell colonies can be detected by 7 to 10 d Analyze the karyotypes of the ES hybrid cells Note 1. Successful formation of pearl chains during AC duration is extremely important for the efficiency of cell fusion. The pearl chain formation is influenced mainly by the following factors: (1) cell density in mannitol • Pellet the mixed cells by centrifugation and resuspend the cells in a suitable amount of fresh 0.3 M mannitol Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion Changing potency by spontaneous fusion Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro Transplanted bone marrow regenerates liver by cell fusion Cell fusion is the principal source of bone-marrow-derived hepatocytes Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant Viable offspring derived from fetal and adult mammalian cells Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells Pluripotency of reprogrammed somatic genomes in embryonic stem hybrid cells Chromatin reprogramming of male somatic cell-derived XIST and TSIX in ES hybrid cells Histone code modifications on pluripotential nuclei of reprogrammed somatic cells Epigenotype switching of imprintable loci in embryonic germ cells Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells Behaviour of differentiated nuclei in heterokaryons of animal cells from different species Plasticity of the differentiated state Rapid reprogramming of globin gene expression in transient heterokaryons Differentiation requires continuous regulation Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice